Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
0.0900
+0.0113
+(14.36%)
At close: 3:50:43 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Expense
1,326.4780
616.7240
1,736.3360
4,986.9700
14.2230
Operating Income
-1,326.4780
-616.7240
-1,736.3360
-4,986.9700
-14.2230
Net Non Operating Interest Income Expense
-321.2440
-564.6230
-870.5330
-151.6210
-1.8060
Pretax Income
-1,647.7220
-1,181.3470
-2,611.8690
-5,138.5910
-16.0290
Net Income Common Stockholders
-1,647.7220
-1,181.3470
-2,611.8690
-5,138.5910
-16.0290
Diluted NI Available to Com Stockholders
-1,647.7220
-1,181.3470
-2,611.8690
-5,138.5910
-16.0290
Basic EPS
-0.13
-0.08
-0.18
-0.38
-0.00
Diluted EPS
-0.13
-0.08
-0.18
-0.38
-0.00
Basic Average Shares
13,223.6820
14,884.0500
14,445.0020
13,412.6340
12,425.4200
Diluted Average Shares
13,223.6820
14,884.0500
14,445.0020
13,412.6340
12,425.4200
Total Operating Income as Reported
-1,326.4780
-616.7240
-1,736.3360
-4,986.9700
-14.2230
Total Expenses
1,326.4780
616.7240
1,736.3360
4,986.9700
14.2230
Net Income from Continuing & Discontinued Operation
-1,647.7220
-1,181.3470
-2,611.8690
-5,138.5910
-16.0290
Normalized Income
-1,647.7220
-1,181.3470
-2,611.8690
-5,138.5910
-16.0290
Interest Income
--
--
--
--
2.2140
Interest Expense
321.2440
564.6230
870.5330
151.6210
1.8060
Net Interest Income
-321.2440
-564.6230
-870.5330
-151.6210
-1.8060
EBIT
-1,326.4780
-616.7240
-1,741.3360
-4,986.9700
-14.2230
EBITDA
-765.5100
-555.5070
-1,740.3350
-4,986.7210
-14.2230
Reconciled Depreciation
560.9680
61.2170
1.0010
0.2490
--
Net Income from Continuing Operation Net Minority Interest
-1,647.7220
-1,181.3470
-2,611.8690
-5,138.5910
-16.0290
Normalized EBITDA
-765.5100
-555.5070
-1,740.3350
-4,986.7210
-14.2230
12/31/2020 - 3/31/2006
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
HAVLF HAVN Life Sciences Inc.
0.0005
-95.00%
IVRN Innoveren Scientific Inc.
0.0004
+33.33%
CHRO Channel Therapeutics Corporation
1.7500
+4.17%
BTAX Biostax Corp.
0.0100
+42.86%
QUIA.ST Quia Pharma AB (publ)
0.0048
-2.04%
EPRX Eupraxia Pharmaceuticals Inc.
3.7630
+3.10%
PPBT.TA Purple Biotech Ltd
5.60
-1.75%
ALZCUR.ST AlzeCure Pharma AB (publ)
1.7300
+4.85%
SNSE Sensei Biotherapeutics, Inc.
0.4628
+2.01%
WSNAF Wesana Health Holdings Inc.
0.0900
-18.18%